Logo image of EQOS

EQONEX LTD (EQOS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EQOS - SGXZ53262598 - Common Stock

0.0931 USD
-0.05 (-33.88%)
Last: 11/29/2022, 8:00:01 PM
0.0869 USD
-0.01 (-6.66%)
After Hours: 11/29/2022, 8:00:01 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EQOS. EQOS was compared to 237 industry peers in the Capital Markets industry. EQOS may be in some trouble as it scores bad on both profitability and health. EQOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EQOS had negative earnings in the past year.
In the past year EQOS has reported a negative cash flow from operations.
EQOS Yearly Net Income VS EBIT VS OCF VS FCFEQOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -20M -40M -60M

1.2 Ratios

EQOS's Return On Assets of -122.39% is on the low side compared to the rest of the industry. EQOS is outperformed by 98.06% of its industry peers.
Industry RankSector Rank
ROA -122.39%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EQOS Yearly ROA, ROE, ROICEQOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 -500 -1K -1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EQOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EQOS Yearly Profit, Operating, Gross MarginsEQOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 1K -1K

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EQOS has more shares outstanding
EQOS has a worse debt/assets ratio than last year.
EQOS Yearly Shares OutstandingEQOS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M
EQOS Yearly Total Debt VS Total AssetsEQOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

EQOS has an Altman-Z score of -11.66. This is a bad value and indicates that EQOS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EQOS (-11.66) is better than 76.21% of its industry peers.
A Debt/Equity ratio of 1.65 is on the high side and indicates that EQOS has dependencies on debt financing.
EQOS has a worse Debt to Equity ratio (1.65) than 82.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.65
Debt/FCF N/A
Altman-Z -11.66
ROIC/WACCN/A
WACCN/A
EQOS Yearly LT Debt VS Equity VS FCFEQOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 20M -20M 40M -40M

2.3 Liquidity

EQOS has a Current Ratio of 1.08. This is a normal value and indicates that EQOS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EQOS (1.08) is better than 80.58% of its industry peers.
A Quick Ratio of 1.08 indicates that EQOS should not have too much problems paying its short term obligations.
EQOS has a Quick ratio of 1.08. This is amongst the best in the industry. EQOS outperforms 81.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
EQOS Yearly Current Assets VS Current LiabilitesEQOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

EQOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1533.22%.
The Revenue has grown by 1741.83% in the past year. This is a very strong growth!
Measured over the past years, EQOS shows a very strong growth in Revenue. The Revenue has been growing by 77.30% on average per year.
EPS 1Y (TTM)-1533.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3194.97%
Revenue 1Y (TTM)1741.83%
Revenue growth 3Y77.3%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

EQOS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.42% yearly.
The Revenue is expected to grow by 52.26% on average over the next years. This is a very strong growth
EPS Next Y63.76%
EPS Next 2Y41.05%
EPS Next 3Y25.6%
EPS Next 5Y18.42%
Revenue Next Year-41.3%
Revenue Next 2Y31.89%
Revenue Next 3Y44.66%
Revenue Next 5Y52.26%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EQOS Yearly Revenue VS EstimatesEQOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
EQOS Yearly EPS VS EstimatesEQOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EQOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EQOS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EQOS Price Earnings VS Forward Price EarningsEQOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EQOS Per share dataEQOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as EQOS's earnings are expected to grow with 25.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.05%
EPS Next 3Y25.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EQOS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EQONEX LTD

NASDAQ:EQOS (11/29/2022, 8:00:01 PM)

After market: 0.0869 -0.01 (-6.66%)

0.0931

-0.05 (-33.88%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)09-06 2022-09-06/bmo
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.31M
Revenue(TTM)5.29M
Net Income(TTM)-75.00M
Analysts45.71
Price Target5.36 (5657.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.81
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)-1.85
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-0.92
OCFYN/A
SpS0.11
BVpS0.09
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -122.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 134.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z -11.66
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)148.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1533.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3194.97%
EPS Next Y63.76%
EPS Next 2Y41.05%
EPS Next 3Y25.6%
EPS Next 5Y18.42%
Revenue 1Y (TTM)1741.83%
Revenue growth 3Y77.3%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-41.3%
Revenue Next 2Y31.89%
Revenue Next 3Y44.66%
Revenue Next 5Y52.26%
EBIT growth 1Y-4878.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.84%
EBIT Next 3Y48.54%
EBIT Next 5Y50.96%
FCF growth 1Y-4716.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3996.89%
OCF growth 3YN/A
OCF growth 5YN/A

EQONEX LTD / EQOS FAQ

What is the ChartMill fundamental rating of EQONEX LTD (EQOS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to EQOS.


What is the valuation status of EQONEX LTD (EQOS) stock?

ChartMill assigns a valuation rating of 1 / 10 to EQONEX LTD (EQOS). This can be considered as Overvalued.


Can you provide the profitability details for EQONEX LTD?

EQONEX LTD (EQOS) has a profitability rating of 1 / 10.


Can you provide the financial health for EQOS stock?

The financial health rating of EQONEX LTD (EQOS) is 1 / 10.